Global estimates of pregnancies at risk of Plasmodium falciparum and Plasmodium vivax infection in 2020 and changes in risk patterns since 2000.
Journal
PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676
Informations de publication
Date de publication:
2022
2022
Historique:
received:
12
04
2022
accepted:
03
10
2022
entrez:
24
3
2023
pubmed:
25
3
2023
medline:
25
3
2023
Statut:
epublish
Résumé
Women are at risk of severe adverse pregnancy outcomes attributable to Plasmodium spp. infection in malaria-endemic areas. Malaria control efforts since 2000 have aimed to reduce this burden of disease. We used data from the Malaria Atlas Project and WorldPop to calculate global pregnancies at-risk of Plasmodium spp. infection. We categorised pregnancies as occurring in areas of stable and unstable P. falciparum and P. vivax transmission. We further stratified stable endemicity as hypo-endemic, meso-endemic, hyper-endemic, or holo-endemic, and estimated pregnancies at risk in 2000, 2005, 2010, 2015, 2017, and 2020. In 2020, globally 120.4M pregnancies were at risk of P. falciparum, two-thirds (81.0M, 67.3%) were in areas of stable transmission; 85 2M pregnancies were at risk of P. vivax, 93.9% (80.0M) were in areas of stable transmission. An estimated 64.6M pregnancies were in areas with both P. falciparum and P. vivax transmission. The number of pregnancies at risk of each of P. falciparum and P. vivax worldwide decreased between 2000 and 2020, with the exception of sub-Saharan Africa, where the total number of pregnancies at risk of P. falciparum increased from 37 3M in 2000 to 52 4M in 2020. Historic investments in malaria control have reduced the number of women at risk of malaria in pregnancy in all endemic regions except sub-Saharan Africa. Population growth in Africa has outpaced reductions in malaria prevalence. Interventions that reduce the risk of malaria in pregnancy are needed as much today as ever.
Sections du résumé
BACKGROUND
BACKGROUND
Women are at risk of severe adverse pregnancy outcomes attributable to Plasmodium spp. infection in malaria-endemic areas. Malaria control efforts since 2000 have aimed to reduce this burden of disease.
METHODS
METHODS
We used data from the Malaria Atlas Project and WorldPop to calculate global pregnancies at-risk of Plasmodium spp. infection. We categorised pregnancies as occurring in areas of stable and unstable P. falciparum and P. vivax transmission. We further stratified stable endemicity as hypo-endemic, meso-endemic, hyper-endemic, or holo-endemic, and estimated pregnancies at risk in 2000, 2005, 2010, 2015, 2017, and 2020.
FINDINGS
RESULTS
In 2020, globally 120.4M pregnancies were at risk of P. falciparum, two-thirds (81.0M, 67.3%) were in areas of stable transmission; 85 2M pregnancies were at risk of P. vivax, 93.9% (80.0M) were in areas of stable transmission. An estimated 64.6M pregnancies were in areas with both P. falciparum and P. vivax transmission. The number of pregnancies at risk of each of P. falciparum and P. vivax worldwide decreased between 2000 and 2020, with the exception of sub-Saharan Africa, where the total number of pregnancies at risk of P. falciparum increased from 37 3M in 2000 to 52 4M in 2020.
INTERPRETATION
CONCLUSIONS
Historic investments in malaria control have reduced the number of women at risk of malaria in pregnancy in all endemic regions except sub-Saharan Africa. Population growth in Africa has outpaced reductions in malaria prevalence. Interventions that reduce the risk of malaria in pregnancy are needed as much today as ever.
Identifiants
pubmed: 36962612
doi: 10.1371/journal.pgph.0001061
pii: PGPH-D-22-00585
pmc: PMC10022219
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e0001061Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Informations de copyright
Copyright: © 2022 Gore-Langton et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Nat Commun. 2013;4:1609
pubmed: 23511473
Lancet Glob Health. 2017 Nov;5(11):e1101-e1112
pubmed: 28967610
Clin Infect Dis. 2008 May 1;46(9):1374-81
pubmed: 18419439
Lancet. 2013 Aug 3;382(9890):417-425
pubmed: 23746775
Nat Microbiol. 2021 Mar;6(3):380-391
pubmed: 33452495
Lancet. 2019 Jul 27;394(10195):322-331
pubmed: 31229234
Lancet Glob Health. 2015 Oct;3(10):e617-28
pubmed: 26296450
Mediterr J Hematol Infect Dis. 2013;5(1):e2013010
pubmed: 23350023
Trop Med Int Health. 2015 Dec;20(12):1621-33
pubmed: 26325263
Lancet. 2019 Jul 27;394(10195):332-343
pubmed: 31229233
Lancet Planet Health. 2021 Jul;5(7):e404-e414
pubmed: 34245711
Am J Trop Med Hyg. 2001 Jan-Feb;64(1-2 Suppl):36-44
pubmed: 11425176
Lancet Infect Dis. 2007 Feb;7(2):105-17
pubmed: 17251081
Infect Immun. 2001 Dec;69(12):7487-92
pubmed: 11705924
PLoS Negl Trop Dis. 2017 Jun 12;11(6):e0005606
pubmed: 28604825
Lancet Infect Dis. 2012 Jan;12(1):75-88
pubmed: 22192132
PLoS Med. 2010 Jan 26;7(1):e1000221
pubmed: 20126256
Sci Data. 2018 May 22;5:180090
pubmed: 29786689
Int J Health Geogr. 2014 Jan 04;13:2
pubmed: 24387010
Lancet Infect Dis. 2018 Apr;18(4):e107-e118
pubmed: 29396010
Clin Infect Dis. 2008 May 1;46(9):1382-4
pubmed: 18419440
Lancet Glob Health. 2020 Jul;8(7):e942-e953
pubmed: 32562650
Lancet. 2020 Oct 17;396(10258):1285-1306
pubmed: 32679112
Nature. 2015 Oct 8;526(7572):207-211
pubmed: 26375008
Lancet. 2020 Oct 17;396(10258):1131-1133
pubmed: 32679113
PLoS Negl Trop Dis. 2019 Jan 31;13(1):e0007140
pubmed: 30703083
Lancet Glob Health. 2021 Jun;9(6):e802-e812
pubmed: 34019836
Nat Med. 2020 Sep;26(9):1411-1416
pubmed: 32770167
Arch Dis Child Fetal Neonatal Ed. 1998 Sep;79(2):F135-40
pubmed: 9828741
J Infect Dis. 2000 May;181(5):1740-5
pubmed: 10823776
Lancet Infect Dis. 2021 Jan;21(1):59-69
pubmed: 32971006
Lancet Infect Dis. 2008 Jun;8(6):369-78
pubmed: 18387849
Malar J. 2021 Sep 6;20(1):361
pubmed: 34488784
Clin Microbiol Rev. 2004 Oct;17(4):760-9, table of contents
pubmed: 15489346
Stud Fam Plann. 2014 Sep;45(3):301-14
pubmed: 25207494